FabiFlu
FabiFlu more economical, effective treatment option for COVID-19: Glenmark tells DGCI
Glenmark also denied making any claims that “favipiravir alone” is effective in treatment of mild-to-moderate COVID-19 patients
Glenmark Pharma cuts price of COVID-19 drug Favipiravir to Rs 75/tablet
Glenmark Pharmaceuticals had launched antiviral drug Favipiravir, under the brand name FabiFlu, last month at a price of Rs 103 per tablet
1 of 1